From Student to AML Patient in Days, Maddie’s Story Shows Why Trials Matter
After relapsing with leukaemia, Maddie aged 24, was out of options—except for one. A clinical trial gave her hope.
'I would not be alive without Cure Leukaemia.'
Lizzie Dean's Story
